Compile Data Set for Download or QSAR
Report error Found 10 Enz. Inhib. hit(s) with all data for entry = 7834
TargetSodium/glucose cotransporter 2(Human)
Xuanzhu Pharma

US Patent
LigandPNGBDBM221893(US9315438, Compound represented by formula (II))
Affinity DataIC50: 2.5nMT: 2°CAssay Description:Human SGLT-2 and SGLT-1 sequences were stably expressed in the CHO cells. The cell culture was conducted in a 96-well plate for 12 hr. The plate was ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/10/2017
Entry Details
Go to US Patent

TargetSodium/glucose cotransporter 2(Human)
Xuanzhu Pharma

US Patent
LigandPNGBDBM221897(US9315438, Reference compound 1)
Affinity DataIC50: 3.63nMT: 2°CAssay Description:Human SGLT-2 and SGLT-1 sequences were stably expressed in the CHO cells. The cell culture was conducted in a 96-well plate for 12 hr. The plate was ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/10/2017
Entry Details
Go to US Patent

TargetSodium/glucose cotransporter 2(Human)
Xuanzhu Pharma

US Patent
LigandPNGBDBM221894(US9315438, Compound represented by formula (III))
Affinity DataIC50: 7.83nMT: 2°CAssay Description:Human SGLT-2 and SGLT-1 sequences were stably expressed in the CHO cells. The cell culture was conducted in a 96-well plate for 12 hr. The plate was ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/10/2017
Entry Details
Go to US Patent

TargetSodium/glucose cotransporter 2(Human)
Xuanzhu Pharma

US Patent
LigandPNGBDBM221896(US9315438, Compound represented by formula (V))
Affinity DataIC50: 282nMT: 2°CAssay Description:Human SGLT-2 and SGLT-1 sequences were stably expressed in the CHO cells. The cell culture was conducted in a 96-well plate for 12 hr. The plate was ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/10/2017
Entry Details
Go to US Patent

TargetSodium/glucose cotransporter 2(Human)
Xuanzhu Pharma

US Patent
LigandPNGBDBM221895(US9315438, Compound represented by formula (IV))
Affinity DataIC50: 1.11E+3nMT: 2°CAssay Description:Human SGLT-2 and SGLT-1 sequences were stably expressed in the CHO cells. The cell culture was conducted in a 96-well plate for 12 hr. The plate was ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/10/2017
Entry Details
Go to US Patent

TargetSodium/glucose cotransporter 1(Human)
Xuanzhu Pharma

US Patent
LigandPNGBDBM221897(US9315438, Reference compound 1)
Affinity DataIC50: 2.40E+3nMT: 2°CAssay Description:Human SGLT-2 and SGLT-1 sequences were stably expressed in the CHO cells. The cell culture was conducted in a 96-well plate for 12 hr. The plate was ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/10/2017
Entry Details
Go to US Patent

TargetSodium/glucose cotransporter 1(Human)
Xuanzhu Pharma

US Patent
LigandPNGBDBM221894(US9315438, Compound represented by formula (III))
Affinity DataIC50: 3.08E+3nMT: 2°CAssay Description:Human SGLT-2 and SGLT-1 sequences were stably expressed in the CHO cells. The cell culture was conducted in a 96-well plate for 12 hr. The plate was ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/10/2017
Entry Details
Go to US Patent

TargetSodium/glucose cotransporter 1(Human)
Xuanzhu Pharma

US Patent
LigandPNGBDBM221893(US9315438, Compound represented by formula (II))
Affinity DataIC50: 1.72E+4nMT: 2°CAssay Description:Human SGLT-2 and SGLT-1 sequences were stably expressed in the CHO cells. The cell culture was conducted in a 96-well plate for 12 hr. The plate was ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/10/2017
Entry Details
Go to US Patent

TargetSodium/glucose cotransporter 1(Human)
Xuanzhu Pharma

US Patent
LigandPNGBDBM221896(US9315438, Compound represented by formula (V))
Affinity DataIC50: 7.55E+4nMT: 2°CAssay Description:Human SGLT-2 and SGLT-1 sequences were stably expressed in the CHO cells. The cell culture was conducted in a 96-well plate for 12 hr. The plate was ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/10/2017
Entry Details
Go to US Patent

TargetSodium/glucose cotransporter 1(Human)
Xuanzhu Pharma

US Patent
LigandPNGBDBM221895(US9315438, Compound represented by formula (IV))
Affinity DataIC50: 1.11E+5nMT: 2°CAssay Description:Human SGLT-2 and SGLT-1 sequences were stably expressed in the CHO cells. The cell culture was conducted in a 96-well plate for 12 hr. The plate was ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/10/2017
Entry Details
Go to US Patent